Metabolism and Immunity: Therapeutic Potential of Polyunsaturated Fatty Acids and Their Derivatives

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".

Deadline for manuscript submissions: closed (15 November 2021) | Viewed by 2366

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmacobiology, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Krakow, Poland
Interests: fatty acids; pro-resolving mediators; inflammation; metabolic stress

Special Issue Information

Dear Colleagues,

Fatty acids (FAs) are precursors of several lipid species and mediators, including phospholipids, sphingolipids and triacylglycerols as well as eicosanoids, endocannabinoids and isoprostanes. FAs are involved in the synthesis of biological membranes and the modulation of their fluidity, functioning as secondary messengers in signaling pathways to maintain homoeostasis, and serving as a form of energy storage in animals. Recent reports clearly indicate that polyunsaturated FAs (PUFAs) and their derivatives are essential for proper growth and development, have immunomodulatory and anti-inflammatory properties, and are resolvers of inflammation. The specific molecular mechanism for the health benefits from n-3 and n-6 PUFAs remain unclear.

Metabolic inflammation is hypothesized to arise from chronic nutrient excess. The relationship between the immune and metabolic responses includes both communicable (infection) and non-communicable diseases (diabetes, CVD, and cancer). A greater understanding of the critical nodes of immune metabolism may provide opportunities to break the tight connections between defects in metabolism and immunity that propagate disease.

The process of the resolution of inflammation, so important for the health of the patient, is still not fully understood. Therefore, characterizing the molecular mechanism of the resolution of inflammation is important. It may allow, inter alia, the development of new strategies, therapeutic aims and modern drugs, essential in the fight against inflammation.

Dr. Joanna Gdula-Argasińska
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • polyunsaturated fatty acids
  • pro-resolving mediators
  • lipidomic remodeling
  • lipid reprogramming
  • immune cells
  • astrocyte–microglia communication
  • bone marrow fat

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 1673 KiB  
Article
Effect of Eicosapentaenoic Acid Supplementation on Murine Preadipocytes 3T3-L1 Cells Activated with Lipopolysaccharide and/or Tumor Necrosis Factor-α
by Anna Zając-Grabiec, Karoline Bartusek, Katarzyna Sroczyńska, Tadeusz Librowski and Joanna Gdula-Argasińska
Life 2021, 11(9), 977; https://doi.org/10.3390/life11090977 - 16 Sep 2021
Cited by 1 | Viewed by 1830
Abstract
The beneficial effect of n-3 fatty acids can be related to anti-inflammatory properties. The aim of the study was to analyzed the effect of eicosapentaenoic acid (EPA) on 3T3-L1 cells (murine embryonic fibroblasts‒preadipocytes) activated with inflammatory factors (IF). Cells were incubated with 50 [...] Read more.
The beneficial effect of n-3 fatty acids can be related to anti-inflammatory properties. The aim of the study was to analyzed the effect of eicosapentaenoic acid (EPA) on 3T3-L1 cells (murine embryonic fibroblasts‒preadipocytes) activated with inflammatory factors (IF). Cells were incubated with 50 µmol of EPA for 48 h, and then activated with lipopolysaccharide (LPS) or tumor necrosis factor-α (TNF-α). The level of cycloxygenase-2 (Prostaglandin-Endoperoxide Synthase 2, PTGS2, COX-2), cytosolic prostaglandin synthase E2 (cPGES), fatty acid binding protein 4 (FABP4), toll-like receptor 4 (TLR4), glucose receptor type 4 (GLUT-4), and cannabinoid receptor 2 (CB2) was determined using Western blot analysis. The phospholipase A2 (Pla2g4a), and prostaglandin-Endoperoxide Synthase 2 (Ptgs2) gene expression was analyzed by real-time qPCR. After EPA and IF activation, a significant decrease in the COX-2, cPGES, and TRL4 protein levels was observed. Incubation of cells with EPA and IF resulted in a decrease in Ptgs2 and an increase in the Pla2g4a gene. A significant increase in the CB2 protein was observed in adipocytes co-treated with EPA and IF. The results indicated an anti-inflammatory properties of EPA. Interestingly, the activation of the GLUT4 receptor by EPA suggests an unique role of this FA in the regulation of the adipocyte metabolism and prevention of insulin resistance. Full article
Show Figures

Figure 1

Back to TopTop